Literature DB >> 8264978

MK-801, an N-methyl-D-aspartate receptor antagonist, blocks quinolinic acid-induced lipid peroxidation in rat corpus striatum.

A Santamaría1, C Ríos.   

Abstract

In this study, we evaluate the possible participation of lipid peroxidation (LP) in the neurotoxic events that follow after quinolinic acid (QUIN) microinjection into the rat corpus striatum. Two hours after QUIN (240 nmol/microliters) intrastriatal administration, lipid peroxidation was found increased by 32% vs. control as measured by thiobarbituric acid-reactive substances (TBARS). At the same time tested, the enhancement in LP was of 55% vs. control as measured by lipid fluorescent products (LFP) formation (a second index of lipid peroxidation employed). The increase of QUIN-induced lipid peroxidation was completely abolished by pretreatment of rats with an N-methyl-D-aspartate (NMDA) receptor antagonist, MK-801 (10 mg/kg, i.p.), 60 min before QUIN microinjection. Results suggest an NMDA receptor involvement in the QUIN-induced oxidative processes.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8264978     DOI: 10.1016/0304-3940(93)90796-n

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  37 in total

1.  Recovery of motor deficit, cerebellar serotonin and lipid peroxidation levels in the cortex of injured rats.

Authors:  Antonio Bueno-Nava; Rigoberto Gonzalez-Pina; Alfonso Alfaro-Rodriguez; Vladimir Nekrassov-Protasova; Alfredo Durand-Rivera; Sergio Montes; Fructuoso Ayala-Guerrero
Journal:  Neurochem Res       Date:  2010-06-10       Impact factor: 3.996

2.  Decreased nitric oxide production in the rat brain after chronic arsenic exposure.

Authors:  Sergio Zarazúa; Francisca Pérez-Severiano; Juan Manuel Delgado; Luz M Martínez; Deogracias Ortiz-Pérez; María E Jiménez-Capdeville
Journal:  Neurochem Res       Date:  2006-07-27       Impact factor: 3.996

3.  Early nerve ending rescue from oxidative damage and energy failure by L: -carnitine as post-treatment in two neurotoxic models in rat: recovery of antioxidant and reductive capacities.

Authors:  Diana Elinos-Calderón; Yolanda Robledo-Arratia; Verónica Pérez-De La Cruz; José Pedraza-Chaverrí; Syed F Ali; Abel Santamaría
Journal:  Exp Brain Res       Date:  2009-06-30       Impact factor: 1.972

4.  Upregulation of neuronal kynurenine 3-monooxygenase mediates depression-like behavior in a mouse model of neuropathic pain.

Authors:  Geoffroy Laumet; Wenjun Zhou; Robert Dantzer; Jules D Edralin; XiaoJiao Huo; David P Budac; Jason C O'Connor; Anna W Lee; Cobi J Heijnen; Annemieke Kavelaars
Journal:  Brain Behav Immun       Date:  2017-07-11       Impact factor: 7.217

5.  Rosiglitazone synergizes the neuroprotective effects of valproic acid against quinolinic acid-induced neurotoxicity in rats: targeting PPARγ and HDAC pathways.

Authors:  Jitendriya Mishra; Tanya Chaudhary; Anil Kumar
Journal:  Neurotox Res       Date:  2014-02-25       Impact factor: 3.911

6.  Improvement of mitochondrial function by paliperidone attenuates quinolinic acid-induced behavioural and neurochemical alterations in rats: implications in Huntington's disease.

Authors:  Jitendriya Mishra; Anil Kumar
Journal:  Neurotox Res       Date:  2014-04-22       Impact factor: 3.911

7.  N-methyl-D-aspartate receptors are involved in the quinolinic acid, but not in the malonate pro-oxidative activity in vitro.

Authors:  Robson Luiz Puntel; Cristina Wayne Nogueira; João Batista Teixeira Rocha
Journal:  Neurochem Res       Date:  2005-03       Impact factor: 3.996

8.  Oxidative stress as a mechanism for quinolinic acid-induced hippocampal damage: protection by melatonin and deprenyl.

Authors:  W M Behan; M McDonald; L G Darlington; T W Stone
Journal:  Br J Pharmacol       Date:  1999-12       Impact factor: 8.739

9.  Homocysteine-induced brain lipid peroxidation: effects of NMDA receptor blockade, antioxidant treatment, and nitric oxide synthase inhibition.

Authors:  Aurelio Jara-Prado; Alberto Ortega-Vazquez; Leticia Martinez-Ruano; Camilo Rios; Abel Santamaria
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

10.  The Ayurvedic drug, Ksheerabala, ameliorates quinolinic acid-induced oxidative stress in rat brain.

Authors:  S S Swathy; M Indira
Journal:  Int J Ayurveda Res       Date:  2010-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.